CMS Cameron McKenna Nabarro Olswang has announced its merger with Ukraine's Danevych.Law, with Founding Partner Borys Danevych becoming Partner and Head of Life Sciences at CMS.
The merger will become effective on November 1, 2020, and Danevych.Law’s legal and administrative team, including Senior Associate Anastasiya Filipiuk, Associates Artem Grudinin and Anastasiya Maistruk, and Administrative Executive Iryna Tvardovska, will also be joining CMS.
“We are delighted to announce this strategic integration and to welcome Borys and his team to the firm," commented CMS Kyiv Managing Partner Graham Conlon. "With Life Sciences increasingly attracting the global spotlight, this important expansion of the team demonstrates our on-going commitment to delivering advice to our clients. The breadth and depth of Borys’s experience, along with the expert support of his committed team, will strengthen and expand our life sciences offering.”
Before establishing his own firm in 2012, Danevych spent ten years at Paritet law firm. He received his Master’s degree from the University of Kyiv Mohyla Academy in 2006. According to CMS, “Borys brings more than 15 years of experience working with international pharmaceutical, biotech, research and development, and medical devices companies, as well as healthcare services and health technology organizations.”
“CMS has a very impressive global Life Sciences group and I see many opportunities to further develop our capabilities for clients in areas such as biotech, brand protection, and health tech," said Borys Danevych. “I also see significant additional value in terms of being able to offer strong transactional, IP, Dispute Resolution, TMT, and Tax capability to our clients going forward. I am excited to join the firm – as are my colleagues from my previous firm. We look forward to working with the team both in Ukraine and across Europe.”